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Summary. A metaplastic process, in which native 
squamous epithelium of the distal esophagus is replaced 
by columnar epithelium, is known as Barrett esophagus 
(BE). Over the past years, intestinal metaplasia was 
recognized as a marker for BE. The  risk for the 
development of esophageal adenocarcinoma in a patients 
with BE is much higher when com~ared to the normal 
" 
population. Duodeno-gastro-esophageal reflux is  
supposed to play a role in the pathogenesis of BE and 
rising incidence of adenocarcinoma of the esophagus. 
With current therapeutic options, when clinical 
manifestation of this cancer occurs, it is too late for cure 
in the majority of patients. Therefore, attention should be 
focused on early diagnosis, for which molecular genetic 
techniques might become available. Current data on 
genetic alterations involved in carcinogenesis of BE are 
discussed. Grading of dysplasia in BE carries important 
clinical consequences for the individual patient: 
intensification of endoscopic surveillance or 
'prophylactic esophagectomy'. Several morpho- andlor 
cytometric parameters may be used for discrimination 
between different grades of dysplasia in BE. Therefore, a 
new and original algorythm for the potential application 
of quantitative pathology in grading of dysplasia in 
patients with BE has been proposed. Molecular biology 
together with image analysis of histological spectrum of 
BE enable better understanding of the mechanisms of 
malignant degeneration and might ultimately lead to 
targeted cancer prevention andlor therapeutic 
interventions. 
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Introduction 
A metaplastic process, in which native squamous 
epithelium of the distal esophagus is replaced by 
columnar epithelium, was already described at the 
beginning of this century (Tileston, 1906). Initially, 
attention was paid to the presence of peptic ulcers in the 
esophagus, lined with gastric-type mucosa (Lyall, 1937; 
Allison, 1948). In 1950, Norman Barrett interpreted this 
condition as a tubular segment of the stomach transposed 
within the chest due to a congenitally short esophagus 
(Barrett, 1950). Since 1953, when Allison and Johnston 
suggested the concept of an esophagus lined with 
columnar epithelium and referred to it as "Barrett ulcer" 
in their publication, Barrett's name was erroneously 
connected to this condition (Allison and Johnstone, 
1953). In the same year, Morson and Belcher described 
cases of esophageal adenocarcinoma arising in 'ectopic' 
gastric mucosa (Morson and Belcher, 1952). After 45 
years, the clinical relevance of Barrett esophagus (BE) is 
i ts malignant potential rather than ulceration 
(Komorowski et al., 1996). Most adenocarcinomas of the 
esophagus or gastro-esophageal junction (GEJ) arise in 
the background of BE (Hamilton et al., 1988). This so- 
called Barrett cancer is now the most rapidly increasing 
malignancy in the Western world (Hesketh et al., 1989; 
Blot et al., 1991, 1993; Powell and McConkey, 1992; 
Pera et al., 1993). The prevalence of BE in patients 
undergoing upper gastro-intestinal endoscopy has been 
estimated at 0.7% (Cameron and Lomboy, 1992). The 
prevalence of BE in autopsy series is over 20 times 
greater than expected based on observations in living 
subjects (Cameron et al., 1990). The true prevalence of 
BE is unknown because the metaplastic mucosa seems to 
be more resistant to the components of gastro- 
esophageal reflux and therefore is  frequently 
asymptomatic. Patients without complications (ulcer, 
structure, carcinoma) often do not seek medical help. 
Therefore, presumably the overwhelming majority of 
patients with BE remain undiagnosed. The premalignant 
character of this condition was established by a 10% 

















